XML 23 R13.htm IDEA: XBRL DOCUMENT
v3.5.0.2

Share-based Compensation | 9 Months Ended
--- | ---
Sep. 30, 2016
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract] |
Share-Based Compensation | Note 8 – Share-Based Compensation On August 27, 2015, the Board of Directors of the Company approved the Golden Entertainment, Inc. 2015 Incentive Award Plan (the “2015 Plan”), which was approved by the Company’s shareholders at the Company’s 2016 annual meeting. The 2015 Plan authorizes the issuance of stock options, restricted stock, restricted stock units, dividend equivalents, stock payment awards, stock appreciation rights, performance bonus awards and other incentive awards. The 2015 Plan authorizes the grant of awards to employees, non-employee directors and consultants of the Company and its subsidiaries. Options generally have a ten-year term. Except as provided in any employment agreement between the Company and the employee, if an employee is terminated (voluntarily or involuntarily), any unvested options as of the date of termination will be forfeited. The maximum number of shares of the Company’s common stock for which grants may be made under the 2015 Plan is 2.25 million shares, plus an annual increase on each January 1 during the ten-year term of the 2015 Plan equal to the lesser of 1.8 million shares, 4% of the total shares of the Company’s common stock outstanding (on an as-converted basis) and such smaller amount as may be determined by the Board in its sole discretion. In addition, the maximum aggregate number of shares of common stock that may be subject to awards granted to any one participant during a calendar year is 2.0 million shares. The annual increase on January 1, 2016 was 874,709 shares. The 2015 Plan provides that no stock option or stock appreciation right (even if vested) may be exercised prior to the earlier of August 1, 2018 or immediately prior to the consummation of a change in control of the Company that would result in an “ownership change” as defined in Section 382 of the Internal Revenue Code of 1986, as amended. There were 2,813,070 stock options outstanding under the 2015 Plan as of September 30, 2016, of which 444,301 have vested. As of September 30, 2016, a total of 311,639 shares of the Company’s common stock remained available for grants of awards under the 2015 Plan. In June 2007, the Company’s shareholders approved the 2007 Lakes Stock Option and Compensation Plan (the “2007 Plan”), which is authorized to grant a total of 1.25 million shares of the Company’s common stock. Vested options are exercisable for ten years from the date of grant; however, if the employee is terminated (voluntarily or involuntarily), any unvested options as of the date of termination will be forfeited. There were 402,671 stock options outstanding under the 2007 Plan as of September 30, 2016, all of which were fully vested. As of September 30, 2016, a total of 282,635 shares of the Company’s common stock remained available for grants of awards under the 2007 Plan. The Company also has a 1998 Stock Option and Compensation Plan (the “1998 Plan”). There were 11,202 stock options outstanding under this plan as of September 30, 2016, all of which were fully vested. No additional options will be granted under the 1998 Plan. Share-based compensation expense related to stock options was $1.7 million and $0.3 million for the three months ended September 30, 2016 and 2015, respectively, and $2.5 million and $0.4 million for the nine months ended September 30, 2016 and 2015, respectively. The Company uses the Black-Scholes option pricing model to estimate the fair value and compensation cost associated with employee incentive stock options, which requires the consideration of historical employee exercise behavior data and the use of a number of assumptions including volatility of the Company’s stock price, the weighted-average risk-free interest rate and the weighted-average expected life of the options. There were 905,000 and 1,128,070 stock options granted under the 2015 Plan during the three and nine months ended September 30, 2016, respectively, with a weighted-average grant date fair value of $4.80 per share and $4.83 per share, respectively. There were 1,610,000 options granted during the three and nine months ended September 30, 2015. The following table summarizes the Company’s stock option activity during the nine months ended September 30, 2016 and September 30, 2015:
|  | Number of Common Shares |  |  | Weighted- |
|  | Options |  |  |  |  |  |  | Available |  |  | Average |
|  | Outstanding |  |  | Exercisable |  |  | for Grant |  |  | Exercise Price |
2016 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at December 31, 2015 |  |  | 2,419,529 |  |  |  | 724,529 |  |  |  | 837,635 |  |  | $ | 8.16 |
Authorized |  |  | — |  |  |  |  |  |  |  | 874,709 |  |  |  | — |
Granted |  |  | 1,128,070 |  |  |  |  |  |  |  | (1,128,070 | ) |  |  | 11.89 |
Options Subject to Anti-Dilutive Adjustments |  |  | (2,337,643 | ) |  |  |  |  |  |  | — |  |  |  | 8.75 |
Options Subject to Anti-Dilutive Adjustments |  |  | 2,337,643 |  |  |  |  |  |  |  | — |  |  |  | 7.04 |
Exercised |  |  | (310,656 | ) |  |  |  |  |  |  | — |  |  |  | 5.73 |
Cancelled |  |  | (10,000 | ) |  |  |  |  |  |  | 10,000 |  |  |  | 9.33 |
Balance at September 30, 2016 |  |  | 3,226,943 |  |  |  | 413,873 |  |  |  | 594,274 |  |  | $ | 8.57 |
2015 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at December 28, 2014 |  |  | 755,617 |  |  |  | 616,792 |  |  |  | 276,635 |  |  | $ | 6.09 |
Authorized |  |  | — |  |  |  |  |  |  |  | 2,250,000 |  |  |  | — |
Granted |  |  | 1,610,000 |  |  |  |  |  |  |  | (1,610,000 | ) |  |  | 9.05 |
Exercised |  |  | (5,000 | ) |  |  |  |  |  |  | — |  |  |  | 7.03 |
Cancelled |  |  | (6,000 | ) |  |  |  |  |  |  | 6,000 |  |  |  | 9.19 |
Balance at September 30, 2015 |  |  | 2,354,617 |  |  |  | 744,617 |  |  |  | 922,635 |  |  | $ | 8.10 |
In connection with the Special Dividend discussed in Note 7, Shareholders’ Equity, and in accordance with the Company’s equity incentive plans approved by the Company’s shareholders, equitable anti-dilutive adjustments were made to the exercise prices of outstanding stock options to purchase shares of Company common stock, in order to preserve the value of such stock options following the Special Dividend. Accordingly, effective as of the close of business on July 14, 2016, the exercise price of each outstanding stock option under the 2015 Plan, the 2007 Plan and the 1998 Plan (collectively, the “Adjusted Options”) was reduced by $1.71 per share. The weighted average exercise price of the Adjusted Options presented in the table above has been adjusted accordingly. The Adjusted Options had a weighted average exercise price of $7.04 per share after giving effect to such anti-dilutive adjustments. The Adjusted Options have varying remaining terms, which were not affected by the adjustments. The Company measured the incremental compensation cost as the excess of the fair value of the Adjusted Options immediately following such anti-dilutive adjustments over the fair value of the Adjusted Options immediately prior to such anti-dilutive adjustments. Of the 2,337,643 Adjusted Options, 1,908,070 were unvested and 429,573 were vested. The incremental fair value related to the unvested Adjusted Options resulting from the anti-dilutive adjustments was estimated to be $1.7 million, which will be recorded over the remaining vesting period of such Adjusted Options. The incremental fair value related to the vested Adjusted Options resulting from the anti-dilutive adjustments, determined using the Black-Scholes option pricing model, was $0.7 million and has been recorded as share-based compensation expense during the three months ended September 30, 2016. As of September 30, 2016, the outstanding stock options had a weighted-average remaining contractual life of 8.3 years, weighted-average exercise price of $8.57 per share and an aggregate intrinsic value of $12.6 million. As of September 30, 2016, the outstanding exercisable stock options had a weighted-average remaining contractual life of 2.0 years, weighted-average exercise price of $4.50 per share and an aggregate intrinsic value of $3.3 million. There were 15,700 and 310,656 options exercised during the three and nine months ended September 30, 2016, respectively. The total intrinsic value of options exercised during the three and nine months ended September 30, 2016 was $0.1 million and $1.7 million, respectively. There were 2,500 and 5,000 options exercised during the three and nine months ended September 30, 2015, respectively. The total intrinsic value of options exercised during both the three and nine months ended September 30, 2015 was less than $0.1 million. The Company’s unrecognized share-based compensation expense related to stock options was approximately $10.9 million as of September 30, 2016, which is expected to be recognized over a weighted-average period of 3.2 years. The Company issues new shares of common stock upon the exercise of stock options.

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=65895303&loc=d3e17540-113929 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 14) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5444-113901 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration